| Not Yet Recruiting | Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Allergic Rhinitis Due to House Dust Mite, Allergic Conjunctivitis Due to Dermatophagoides Farinae, Allergic Conjunctivitis Due to Dermatophagoides Pteronyssinus | — | 2025-07-30 |
| Terminated | Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials Allergic Rhinoconjunctivitis, Healthy Volunteers | Phase 2 | 2014-01-01 |
| Completed | Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunct Allergic Rhinoconjunctivitis | Phase 2 | 2010-10-01 |
| Completed | 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma Rhinoconjunctivitis, Allergic Asthma | Phase 3 | 2009-10-01 |
| Completed | Open Label Safety Study of a Birch Pollen Allergen Extract Rhinoconjunctivitis | Phase 2 | 2008-06-01 |
| Completed | Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation Allergy, Rhinitis, Conjunctivitis | Phase 3 | 2008-03-01 |
| Completed | Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Rhinoconjunctivitis | Phase 3 | 2008-03-01 |
| Completed | Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children Allergic Rhinoconjunctivitis | Phase 3 | 2008-02-01 |
| Completed | Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative Allergic Rhinoconjunctivitis | Phase 2 | 2007-12-01 |
| Completed | Multicenter Trial of Immunotherapy With House Dust Mite Allergoid Rhinoconjunctivitis | Phase 3 | 2007-10-01 |
| Completed | Efficacy and Safety From a Recombinant Folding Variant of Bet v 1 Allergy | Phase 3 | 2007-09-01 |
| Completed | Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens Type I-Allergy | Phase 2 | 2007-09-01 |
| Completed | Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mi Type I Allergy | Phase 4 | 2007-03-01 |
| Completed | Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Bi Pollen Allergy | Phase 3 | 2005-06-01 |
| Completed | Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma Respiratory Hypersensitivity | Phase 3 | 2005-05-01 |
| Completed | Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctiv Allergy | Phase 3 | 2004-01-01 |
| Completed | Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis Birch Pollen Allergy | Phase 3 | 2003-12-01 |
| Completed | Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV Birch Pollen Allergy | Phase 2 | 2003-07-01 |
| Completed | Efficacy and Safety of a Purified Standardised Bee Venom Preparation Bee Venom Allergy | Phase 3 | 2003-03-01 |
| Completed | Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture Grass Pollen Allergy | Phase 3 | 2003-02-01 |
| Completed | Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis House Dust Mite Allergy | Phase 4 | 2002-09-01 |
| Completed | Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis Grass Pollen Allergy | Phase 3 | 2001-11-01 |
| Completed | Efficacy and Safety of a Purified Standardised Wasp Venom Preparation Allergy | Phase 3 | 2001-03-01 |